For the Inventor, By the Inventor

Enter assignee name

Loc. Ospedaletto, Italy

Abiogen Pharma S.p.a.

USPTO Granted Patents = 15

% Expired Patents = 20.0

CIPO Patents = 2

EPO Patents = 10

Forward Citations = 54

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Silvia Trasciatti (5 out of 5 patents)

Fabio Neggiani (4 out of 4 patents)

Stefano Luca Giaffreda (2 out of 9 patents)

4. Laura Dini (2 out of 2 patents)

5. Serena Fabbroni (2 out of 4 patents)

6. Michel Chiarucci (2 out of 4 patents)

7. Barbara Politi (2 out of 2 patents)

8. Elio Napolitano (2 out of 3 patents)

9. Giorgio Valentini (2 out of 2 patents)

10. Claudio Menicagli (2 out of 3 patents)

11. Sergio Rosini (2 out of 10 patents)

12. Michael Chorev (1 out of 15 patents)

13. Samuele Zanatta (1 out of 1 patent)

14. Alex Petrolati (1 out of 1 patent)

15. Kesheng Zhang (1 out of 2 patents)

15 patents: Sort by Forward Citations

1. 12083133 - Use of cholecalciferol as adjuvant in the treatment of muscular dystrophies (2024-09-10),

2. 11512104 - Process for the preparation of the polymorph F of sodium neridronate (2022-11-29),

3. 11123354 - Method for the treatment of osteoarthritis (2021-09-21),

4. 11058138 - Composition for calcium supplementation (2021-07-13),

5. 10815257 - Polymorph of sodium neridronate and preparation process thereof (2020-10-27),

6. 10736856 - Use of xibornol as active agent in the treatment of viral infections (2020-08-11),

7. 9943540 - Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid (2018-04-17),

8. 7968748 - Process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest (2011-06-28),

9. 7872007 - Process for the preparation of 2-(4-hydroxy-3-morfolynil)-2-cyclohexenone (2011-01-18),

10. 7678571 - Procedure for the large-scale T-lymphocytes culture in a homogeneous system (2010-03-16),

11. 7132394 - PTH-like peptides (2006-11-07),

12. 7077297 - Method for preparation of biocides mixed with carbon dioxide in a pressurized container (2006-07-18),

13. 6761289 - Preparation and metering of components mixed with Co2 (2004-07-13),

14. 6387674 - Catalytic monoclonal antibodies with protease activity for selective lysis of protein component of plaques aggregates pathological conditions (2002-05-14),

15. RE37330 - Glibenclamide-metformin combination for the treatment of diabetes mellitus of type II (2001-08-14),

Abiogen Pharma S.p.a. is a biopharmaceutical company based in Loc. Ospedaletto, Italy, specializing in the development and manufacturing of innovative therapeutic solutions. The company focuses on areas such as rare diseases, metabolic disorders, and other specialized medical needs, leveraging advanced research and technology to enhance patient care. With a commitment to scientific excellence, Abiogen Pharma aims to address unmet medical needs through its diverse portfolio of products and ongoing research initiatives.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Abiogen Pharma S.p.a.

15 Patents

#1 in Loc. Ospedaletto

#614 in Italy

#39,881 in the World

Loc. Ospedaletto, Italy

Abiogen Pharma S.p.a.

Forward Citations = 54

31 inventors:

Silvia Trasciatti (5 out of 5 patents)

Fabio Neggiani (4 out of 4 patents)

Stefano Luca Giaffreda (2 out of 9 patents)

4. Laura Dini (2 out of 2 patents)

5. Serena Fabbroni (2 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…